A. Zee

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

Jacqueline A. Hall, Robert Brown, H. Hollema, 2006, British Journal of Cancer.

Prediction of lymph node metastases in vulvar cancer: a review.

H. Hollema, A. V. D. Van Der Zee, J. D. de Hullu, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Sentinel lymph node detection in locally recurrent carcinoma of the vulva

H. Hollema, D. Piers, J. Aalders, 2001, BJOG : an international journal of obstetrics and gynaecology.

P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1991, Cancer research.

Margin status revisited in vulvar squamous cell carcinoma.

H. Hollema, G. D. de Bock, J. Bulten, 2019, Gynecologic oncology.

A four‐gene methylation marker panel as triage test in high‐risk human papillomavirus positive patients

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2012, International journal of cancer.

The Clinical Value of Squamous Cell Carcinoma Antigen in Cancer of the Uterine Cervix

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 1998, Tumor Biology.

Prediction of lymph node metastases in vulvar cancer: a review

H. Hollema, A. van der Zee, J. D. de Hullu, 2005, International Journal of Gynecologic Cancer.

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

H. Hollema, D. Boll, M. van der Aa, 2017, European journal of cancer.

Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ovarian cysts in women receiving tamoxifen for breast cancer

E. Vries, W. Sluiter, P. Willemse, 1999, British Journal of Cancer.

Debulking surgery for ovarian epithelial cancer performed by a gynaecological oncologist improved survival compared with less specialised surgeons.

E. D. de Vries, A. V. D. van der Zee, M. Engelen, 2006, Cancer treatment reviews.

Loss of MSH2 protein expression is a risk factor in early stage cervical cancer

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2006, Journal of Clinical Pathology.